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Background: DNA methylation plays crucial roles in epigenetic gene regulation in normal development and
disease pathogenesis. Efficient and accurate quantification of DNA methylation at single base resolution can greatly
advance the knowledge of disease mechanisms and be used to identify potential biomarkers. We developed an
improved pipeline based on reduced representation bisulfite sequencing (RRBS) for cost-effective genome-wide
quantification of DNA methylation at single base resolution. A selection of two restriction enzymes (TaqαI and MspI)
enables a more unbiased coverage of genomic regions of different CpG densities. We further developed a highly
automated software package to analyze bisulfite sequencing results from the Solexa GAIIx system.
Results: With two sequencing lanes, we were able to quantify ~1.8 million individual CpG sites at a minimum
sequencing depth of 10. Overall, about 76.7% of CpG islands, 54.9% of CpG island shores and 52.2% of core
promoters in the human genome were covered with at least 3 CpG sites per region.
Conclusions: With this new pipeline, it is now possible to perform whole-genome DNA methylation analysis at
single base resolution for a large number of samples for understanding how DNA methylation and its changes are
involved in development, differentiation, and disease pathogenesis.
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Epigenetics is the study of heritable changes in gene
expression without altering the DNA sequence. DNA
methylation, by the addition of a methyl group to the
carbon-5 position of the cytosine residues, is one im-
portant epigenetic regulatory mechanism [1]. In mam-
malian development, genome-wide de novo methylation
occurs during germ cell development and implant-
ation, while genome-wide demethylation occurs during
primordial germ cell development and shortly after
fertilization [2]. DNA methylation and demethylation
also occur during cell differentiation and reprogramming
[3]. Abnormal DNA methylation levels, either hyper-
methylation or hypomethylation in specific genes, are* Correspondence: cmding@gmail.com
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stated.also frequently observed in pathologic states, particularly
in cancer [4].
Accurate quantification of DNA methylation is essential
to decipher mechanisms and pathways regulated epigenet-
ically in development and pathogenesis. Many techniques
have been developed for the detection and quantification
of DNA methylation [reviewed by [5,6]].
The combination of bisulfite conversion and high-
throughput sequencing (Bis-Seq) offers the most quantita-
tive method for DNA methylation analysis at single base
resolution. Unmethylated cytosine is converted to uracil
by sodium bisulfite treatment while methylated cytosine
remains unchanged [7]. Genomic DNA after bisulfite
conversion is amplified by PCR and then sequenced at
high depth, yielding quantitative measurements of in-
dividual cytosine methylation.
While genome-wide Bis-Seq was achieved, published
studies typically only analyzed a few samples from cultured. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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dreds of clinical samples, reduced representation bisulfite
sequencing (RRBS) may be the method of choice [11]. The
RRBS method makes use of restriction enzyme digestion to
selectively analyze genomic regions enriched for CpG sites
in a methylation-independent manner, thus achieving a
high coverage of CpG rich regions while greatly reducing
sequencing read requirement. The current RRBS protocol
uses one single enzyme MspI targeting 5′-CCGG-3′
for DNA fragment selection, which results in selectively
covering CpG rich regions [12]. However, coverage for non
CpG rich regions is generally poor. Recent epigenomic data
suggest that CpG poor regions distal to core promoters per-
form important regulatory functions [8]. Thus, an improve-
ment over the current RRBS protocol to cover CpG poor
regions is essential.
In this paper, we performed a comprehensive in silico
analysis of restriction enzyme digestion of the human
genome. A combination of two enzymes, TaqαI and MspI,
yielded the most desirable coverage of the CpG sites in
both CpG rich and CpG not-so-rich regions. We also de-
scribe how Bis-Seq data are analyzed. We believe a detailed
description of the entire improved RRBS pipeline would
greatly facilitate epigenomic studies requiring the analysis
of large numbers of samples.
Results
We made key improvements in genome-wide DNA
methylation analysis by RRBS, in both the experiment
steps and the data analysis pipeline. Firstly, through ex-
tensive in silico analysis we chose to digest the human
genomic DNA with a combination of two enzymes,
MspI and TaqαI, which allowed us to cover both CpG
islands (CGIs) as well as genomic regions outside CGIs.
Secondly, we removed a size range between 198 to 206 bp
(with the adaptor) that are repetitive sequence rich. Lastly,
we developed a highly automated bioinformatics pipeline
with a detailed step-by-step explanation of both quality
control and data analysis.
We used the above pipeline for the analysis of a large
number of clinical samples such as human placenta, um-
bilical cord and leukocytes. As an example, we provide
data generated from one human buffy coat DNA.
Selection of restriction enzymes and DNA fragment
size range
We systematically analyzed 289 motifs recognized by
restriction enzymes with in silico digestion of the human
genome (GRCh37/hg19, Feb. 2009 Assembly). Further
analyses were carried out with the following consider-
ations: 1) CpG methylation sensitivity and commercial
availability of the restriction enzymes; 2) genome-wide
coverage of the different genomic regions [promoters
(defined as −1000 bp to +500 relative to a transcriptionstart site), CGIs, CpG island shores (CGSs), gene bod-
ies, transcription termination regions (TTRs, defined
as −500 bp to +500 bp relative to a transcription ter-
mination site)] in the fragments generated by enzyme
digestions; 3) size distribution of the fragments; and 4)
single enzyme digestion and double enzyme digestions.
In the end, MspI and TaqαI double enzyme digestion was
chosen for the RRBS protocol. A total of 3,810,058 frag-
ments from the human genome are generated by double
digestion of the two enzymes, among which 450,689
fragments are between 80 to 160 bp. Within the range of
80 to 160 bp, there is an enrichment of repetitive sequences
between 128 to 136 bp, as predicted by in silico digestion
and validated by a clear DNA band at this size range by
gel electrophoresis (around 200 bp with the adaptors)
(Figure 1). We removed this DNA band in the lab protocol.
We compared the in silico digested DNA fragments
(80–160 bp) by MspI and TaqαI double digestion and
MspI single digestion (single digestion is from the original
RRBS protocol). With double digestion, we observed
(Table 1) substantial improvements in CpGs in non-CGI
regions (41.8% increase), as well as modest improvements
in total CpGs in CGIs (7.4% increase), CGIs (6.3% increase)
and promoters (12.7% increase).
Quality control for sequencing results
Our pipeline assesses DNA library and sequencing result
quality in a number of different aspects.
Quality of sequencing reads
Each flow cell used for DNA sequencing contains eight
lanes. Each lane contains 120 tiles. We quantified the
number of total reads and the number of good reads
(passing a cut-off score of 30) for each tile (Additional file 1:
Figure S1). Typically, percentages of good reads were
around 70-90%. Additionally, we assessed the percent-
age of alignment for each library. A typical alignment
percentage defined as number of uniquely aligned reads
over total pass filtered reads was around 55-65%.
Library quality
The preparation protocol for sequencing library by RRBS
results in a number of predictable features. Firstly, the
first three nucleotides for read 1 of paired-end sequen-
cing should be either CGG/TGG (MspI), or CGA/TGA
(TaqαI) for the enzymatically generated fragments, while
those for read 2 should be CAA. Indeed, these predicted
sequencing ends were dominant (97.8% for CGG/TGG/
CGA/TGA in read 1 and 91.9% for CAA in read 2)
(Additional file 1: Table S1). Secondly, read 1 should
map to the positive strand of C2T reference genome, or
negative strand of G2A reference genome, while read 2
should be the exact opposite to read 1. This was also
confirmed after sequencing alignment (Additional file 1:
Figure 1 (See legend on next page.)
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Figure 1 Key laboratory steps in RRBS. The isolated DNA from the samples are digested by two restriction enzymes (TaqαI and MspI). The
fragments are then end-repaired and ligated with adapters. The ligated DNA are size-selected and repetitive sequences are removed. PCR
amplification is performed after bisulfite conversion. Illumina GAIIx system is used for high-throughput sequencing. Newly added bases
(marked in bold in step 2) are always unmethylated and thus discarded in the downstream analysis for CpG methylation.
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guanine in each read follows a specific pattern. The C/G
ratio should be <1 in read 1 and >1 in read 2, as was seen
in the sequencing reads (Additional file 1: Table S3).
Fourthly, the size distribution of library inserts was
analyzed. As expected, the fragment size ranged from
80 to 160 bp, with low abundance shown around 130 bp
since we removed the repetitive sequences around this
size range (Additional file 1: Figure S2).
Bisulfite conversion rate
We estimated the conversion rate using cytosines in non-
CpG regions, assuming any unconverted cytosine was due
to incomplete conversion. This is likely to over-estimate
the non-conversion rate, particularly in samples with
cytosine methylation in non-CpG sites, such as in embry-
onic stem cells [10].
Removal of CpGs with potential polymorphisms
As polymorphisms within known CpG sites are likely
to cause wrong interpretation of DNA methylation, we
implemented a filtering step. A CpG site was discarded if
a probable polymorphism was identified. As an example,
in one sample we removed 25,135 CpGs out of 1,282,265
CpGs with a minimum sequencing depth of 10.
Coverage cutoff
We used a minimum sequencing depth of 10 as the cutoff
for inclusion for DNA methylation analysis. However,
it is possible that a lower cutoff may be sufficient for
many downstream analyses, as suggested by a compari-
son between RRBS and Illumina Infinium 450 K array
[13]. The numbers of CpG sites at different depth were
shown in Figure 2A.
Coverage of CpGs in different genomic regions
Approximately 1.8 million CpG sites with minimum
sequencing depth of 10 were included in the analyses.Table 1 Comparison of in silico digestions (double vs. single d
Covered by MspI
single digestion
CpGs in CGI regions 1,098,462
CpGs in non-CGI regions 1,919,174
CGIs* 20,227
Promoters* (−1000 to +500 bp) 24,520
*by at least 3 CpGs covered in the genomic region.As shown in Figure 2B, 41% of the CpG sites were lo-
cated within the CGIs, 13% of them were located in
CGSs and the remaining CpG sites (46%) were located
in CpG poor regions outside of CGIs or CGSs.
As shown in Figure 2C, 18% of the CpG sites were lo-
cated in the promoter regions overlapping with CGIs
while 4% of the CpG sites were located in the promoter
regions not overlapping with CGIs. Additionally, 39% of
the CpG sites were in intragenic regions, 37% of them
were in the intergenic regions and the remaining 2%
were in the TTR regions.
Genomic regions with at least three CpGs covered at a
minimum sequencing depth of 10 were considered to be
covered. With 2 lanes of Solexa sequencing, we achieved
52.2% coverage for core promoters, 76.7% coverage for
CGIs and 54.9% coverage for CGSs (Table 2).
As shown in Figure 2D, 13% of the covered regions
overlapped with CGIs, 17% of them overlapped with CGSs
and the remaining regions (70%) were located outside of
CGIs or CGSs.
As shown in Figure 2E, 62% of covered regions were
in the intergenic regions. Only 6% of the covered regions
were in the promoters overlapping with CGIs and 3%
were in the promoters not overlapping with any CGI.
Twenty eight percent of the regions were found in the
intragenic regions and the remaining 2% were in the
TTR regions.
Discussion
Epigenetics changes such as chromatin assembly, histone
modifications and DNA methylations are mediators
between gene and environment by regulating genomic
structures and gene transcription. Genome-wide DNA
methylation profiling of human cohorts (or epigenome
wide association studies, EWASs) may complement genetic
association studies in identifying genes involved in complex
diseases. A number of platforms are available for “genome-
wide” DNA methylome analysis. True genome-wide DNAigestion)
Covered by MspI and
TaqαI double digestion
Percentage of increase





Figure 2 (See legend on next page.)
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Figure 2 Coverage of CpGs and genomic regions by RRBS. (A) An example for number of CpG sites with different minimum sequencing
depths; (B) Distribution of CpGs in CGIs/CGSs/Others, using a sequencing depth≥ 10 as the cutoff; (C) Distribution of CpGs in Promoter/TTR/
Intragenic/Intergenic regions; (D) Distribution of genomic regions in CGIs/CGSs/others. (E) Distribution of genomic regions in promoter/TTR/
Intragenic/Intergenic regions. A genomic region was considered covered if at least three CpGs within the region were sequenced at
a depth≥ 10.
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most comprehensive coverage, yet it is cost prohibitive for
analyzing a reasonable number of samples. Two platforms,
Illumina 450 K Infinium Array and RRBS, appear to be the
immediate choices for EWASs [14]. One potential problem
with the 450 K Array and the current RRBS approach
is poor coverage for CpG poor regions, which may miss
important regulatory regions [8].
Through extensive in silico enzyme digestion of the
human genome, we selected a combination of two en-
zymes (TaqαI and MspI) for a more unbiased coverage
of the human genome. We further removed a DNA frag-
ment size range enriched for repetitive sequences so that
more reads are usable for alignment. We provide here a
comprehensive description for the entire process of the
improved RRBS pipeline so that it can be easily adopted
by researchers. We also extensively compared the RRBS
and 450 K Array platforms by analyzing seven umbilical
cord DNA samples with both methods [13]. The two
methods are highly complementary as they cover mostly
different CpGs and genomic regions. Thus, it is possible
to combine the two methods for a more complete cover-
age for EWASs.
Conclusions
With this new pipeline, it is now possible to perform
whole-genome DNA methylation analysis at single base
resolution for a large number of samples for understanding
how DNA methylation and its changes are involved in
development, differentiation, and disease pathogenesis.
Methods
Experimental protocol
A schematic view for the key steps in the lab protocol is
outlined in Figure 1.
DNA isolation and restriction enzyme digestion
One to five microgram of high molecular weight (>10 kb)
genomic DNA was used for each library preparation. EachTable 2 Genome-wide coverage by RRBS
Total in human genome
CpGs 56,434,896
CGIs 27,718
CGSs (±2 KB from CGI) 49,300
Promoters (−1000 to +500 bp) 44,399DNA sample was subjected to sequential restriction enzyme
digestion with MspI and TaqαI (New England Biolabs).
Briefly, DNA was first incubated with 150 U of MspI in a
80 μL system containing 1× Buffer 4 for 2 hrs at 37°C, and
the enzyme was inactivated by heating at 80°C for 20 min.
Additional 20 μL solution containing 150 U of TaqαI,
1× Buffer 4 and 1 μL of 100× BSA was added to the same
reaction tube, and the DNA sample was further incu-
bated at 65°C for 2 hrs. The second enzyme was then
inactivated by heating at 80°C for 20 min. The double-
digested product was purified with the QIAquick PCR
Purification Kit (QIAGEN GmbH, Germany), and all
was used for library preparation.
End repair and adapter ligation
The DNA fragments with 5′-CG-3′ overhangs generated
by the restriction enzyme digestion were end-repaired,
3′-end-adenylated, and adapter-ligated using the ChIP-
Seq Sample Preparation Kit (Illumina). Illumina’s RRBS
for Methylation Analysis protocol was followed, except
that 10 μL of Early Access Methylation Adapter Oligo
(Illumina) was used and the ligation was performed for
15 min at 20°C in the adapter-ligation step.
Size selection of adapter-ligated fragments
Two different sizes of fragments (150–197 bp and
207–230 bp) were selected by gel electrophoresis with
3% agarose gel, corresponding to DNA fragments of
80 to 160 bp without the adapter. DNA fragments with
high abundance of repetitive sequences (between 198 to
206 bp with the adaptor, based on in silico analysis)
were removed using GeneCatcher Gel Excision Kit
(Gel Company), and the remaining fragments between
150 to 230 bp were purified by MinElute Gel Extraction
Kit (QIAGEN GmbH, Germany).
Bisulfite conversion and amplification
The purified fragments were then subject to bisulfite
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The converted DNA was PCR amplified with 1x reaction
buffer, an additional 1.5 mM of MgCl2, 300 μM of dNTP
mix, 500 nM each of PCR primer PE 1.0 and 2.0, and 2.5 U
of HotStarTaq DNA polymerase (QIAGEN). The thermo-
cycling condition was 15 min at 94°C for heat activation,
and 8–12 cycles of 20 sec at 94°C, 30 sec at 65°C and
30 sec at 72°C, followed by a 5-min final extension at 72°C.
The PCR products were purified by gel electrophoresis.
Quantification and quality check of DNA libraries
and sequencing
The DNA libraries were quantified using Agilent 2100
Bioanalyzer (Agilent Technologies). Typically final libraries
contain 200 fmoles of fragments. Paired-end sequencing
(2 × 36 bp) was performed on the Illumina Genome
Analyzer IIx platform, as per manufacturer’s instructions.Figure 3 Sequencing reads alignment to two reference genomes, C2T
the Bowtie program, reads alignment needs to be performed using the tw
made subsequently to remove reads not uniquely aligned. At the end, sets
and D are read pairs aligned to the G2A reference genome.Data analysis pipeline
Reference genome conversion
The human reference genome was converted into two refer-
ence genomes corresponding to the forward strand (Watson
Strand) and the reverse strand (Crick Strand). The C2Tcon-
verted reference genome was derived by converting all cyto-
sines to thymines. The G2A converted reference genome
was derived by converting all guanines to adenosines.
Initial quality control of sequencing reads
The paired-end 36 bp reads were filtered based on their
Phred scores [15], using a cutoff of 30 [16] which indi-
cates a base calling error of 0.001.
The quality of reads was examined by plotting the num-
ber of total reads and the numbers of reads passing the
quality cut-off score from each of the 120 tiles of each
sequencing lane (Additional file 1: Figure S1).and G2A reference genomes. Due to the pointer size limitation by
o reference genomes separately. Cross check and comparison are
A and C are read pairs aligned to C2T reference genome, while sets B
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should end with specific tri-nucleotides such as CGG/
TGG/CGA/TGA/CAA while DNA fragments from random
shearing may end with any sequence. Thus sequencing
library quality was also assessed by calculating the per-
centages of reads ending by expected tri-nucleotides.
Reads conversions
The design of the assays predicts that read 1 sequence
should have a C/G ratio < 1 while read 2 sequence should
have a C/G ratio > 1, if bisulfite conversion is complete
and there is no non-CpG cytosine methylation. Thus, only
paired-end reads that followed the above rules were used.
Sequence alignment
Bowtie, an ultrafast, memory-efficient short read aligner
was used for aligning the sequencing reads [17]. Unfortu-
nately, Bowtie cannot hold a combined index for both C2T
and G2A reference genomes due to the fact that it uses a
32-bit pointer and thus it can handle up to a theoretical
maximum of 232-1 (slightly more than 4 billions). Thus,
two separate Bowtie indexes were created for the C2T and
G2A reference genomes, respectively. We thus developed
a process for sequencing reads alignment (Figure 3).
All pass-filtered, converted reads were aligned to the C2T
and G2A reference genomes separately, using paired-end
reads alignments. Reads set X (4,994,072 pairs) were those
read pairs that aligned uniquely to the C2T reference
genome, while set Y (4,962,237) were those that aligned
uniquely to the G2A reference genome. Overlapping
read pairs between set X and set Y (415,389) were then
compared between the C2T and G2A alignments with
regards to the number of mismatched bases, resulting in
further separation of sets C (139.834), D (145,233) and
E (130,322). The read pairs in set X not overlapping with
set Y were then aligned to the G2A reference genome for
further comparison, resulting in set A (4,440,717). Similarly,
set B was obtained.
At the end, sets A and C were read pairs aligned to C2T
reference genome, while sets B and D were read pairs
aligned to the G2A reference genome. All other read pairs
were discarded since they were not able to align uniquely
to the combined C2T and G2A reference genomes.
Excluding newly filled-in Cytosines
The newly added cytosines in the “End Repair” step are
always unmethylated, regardless of their original methyla-
tion status. Such cytosines were excluded in our analysis
(Figure 1).
Removing of CpGs overlapping with potential
polymorphisms
Polymorphisms overlapping with CpGs may introduce
abnormalities in the data. In this regard, CpG sites withpercentage of dinucleotide ‘XY’ other than ‘CG’ or ‘TG’
greater than 20% were deemed to be probably polymorphic
for the sample and were excluded for further analysis.
Calculating each CpG sequencing depth and methylation level
Methylation level of each CpG site was calculated as
below:
Methylation level for a CpG = Count of Cytosine/
(Count of Cytosine + Count of Thymine)*100%.
Cytosines in non-CpG positions were used to calculated
bisulfite conversion rate, assuming any unconverted cyto-
sine was due to incomplete conversion.
The pipeline is available for academic, non-commercial
use upon request.
Additional file
Additional file 1: Figure S1. Assessment of Reads Quality for Each
Sequencing Run. Good: read pairs passing the Phred score cutoff of 30.
Total: total raw read pairs. Figure S2. Distribution of Library Insert Length.
Table S1. Counts of the first three nucleotides in the sequencing reads.
For read 1, the first three nucleotides were expected to be CGG/TGG/
CGA/TGA. For read 2, the first three nucleotides were expected to be
CAA. Table S2. Number of reads aligned to the positive or negative
strand of the two converted reference genomes. C2TRef: C2T reference
genome; G2ARef: G2A reference genome. Table S3. C/G ratios in the
sequencing reads. In the first three cases (row 2 to 4), the read pairs
showed expected C/G ratios and were thus used for alignment. All others
(row 5) were excluded for further analysis.
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